中文 | English
Return
Total: 93 , 1/10
Show Home Prev Next End page: GO
MeSH:(Ticlopidine/*analogs )

3.Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome.

Cheng XIE ; Xiao-Liang DING ; Ling XUE ; Bin JIANG ; Yong-Fu HANG ; Jie GAO ; Li-Yan MIAO

Acta Pharmaceutica Sinica 2014;49(10):1426-1432

5.Toxic epidermal necrolysis after percutaneous coronary intervention: which drug is the culprit?

Xu-Min HOU ; Wen-Yu WU

Chinese Medical Journal 2011;124(3):467-468

6.Impact of clopidogrel carboxylic metabolite SR26334 on gene expression profile of human umbilical vein endothelial cell line.

Xian-Feng LIU ; Xue-Chun LU ; Jian CAO ; Yan GAO ; Cong MA ; Yun LUO ; Li FAN

Journal of Experimental Hematology 2012;20(3):710-716

8.Identification of the polymorphs of clopidogrel bisulfate based on the steric morphology parameters of crystals.

Long CHEN ; Liu-yi WANG ; Xian-zhen YIN ; Jin-can WANG ; Rui-hao LIU ; Dan WANG ; Hai-yan LI ; Wei-feng ZHU ; Ji-wen ZHANG

Acta Pharmaceutica Sinica 2013;48(9):1459-1463

9.The Influence of Hypothermia on Transfusion Requirement in Patients Who Received Clopidogrel in Proximity to Off-Pump Coronary Bypass Surgery.

Bo Ra LEE ; Jong Wook SONG ; Young Lan KWAK ; Kyoung Jong YOO ; Jae Kwang SHIM

Yonsei Medical Journal 2014;55(1):224-231

10.Polymorphs of clopidogrel bisulfate.

Yi LIU ; Hai-Wei HUANG ; Jian-Min WU ; Ya-Qin SHI ; La-Hu YANG

Acta Pharmaceutica Sinica 2013;48(8):1358-1360

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 93 , 1/10 Show Home Prev Next End page: GO